Jasper Therapeutics, Inc. (JSPR)
0.6932
-0.02
(-2.28%)
USD |
NASDAQ |
Sep 09, 13:39
Jasper Therapeutics Total Liabilities (Quarterly) : 10.39M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.39M |
| March 31, 2026 | 15.52M |
| December 31, 2025 | 29.36M |
| September 30, 2025 | 43.63M |
| June 30, 2025 | 20.70M |
| March 31, 2025 | 13.09M |
| December 31, 2024 | 15.96M |
| September 30, 2024 | 13.47M |
| June 30, 2024 | 11.36M |
| March 31, 2024 | 10.47M |
| December 31, 2023 | 14.68M |
| September 30, 2023 | 16.27M |
| June 30, 2023 | 11.70M |
| March 31, 2023 | 11.30M |
| Date | Value |
|---|---|
| December 31, 2022 | 10.67M |
| September 30, 2022 | 10.94M |
| June 30, 2022 | 10.98M |
| March 31, 2022 | 11.84M |
| December 31, 2021 | 23.86M |
| September 30, 2021 | 28.61M |
| June 30, 2021 | 14.26M |
| March 31, 2021 | 11.10M |
| December 31, 2020 | 14.45M |
| September 30, 2020 | 3.680M |
| June 30, 2020 | 3.758M |
| March 31, 2020 | 3.671M |
| December 31, 2019 | |
| September 30, 2019 | 0.0788M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.80M |
| Shareholders Equity (Quarterly) | 1.413M |
| Debt to Equity Ratio | 0.1911 |
| Current Ratio | 1.475 |
| Net Debt Paydown Yield | 3.92% |